Pfizer Korea wins Lyrica patent infringement case

Published: 2013-05-24 06:59:00
Updated: 2013-05-24 06:59:00
The Seoul Central District Court ruled Wednesday that CJ Cheil Jedang had infringed on Pfizer’s Lyrica patent.

Lyrica, also known as Pregabalin, is used to treat chronic pain disorders like fibromyalgia and other neuropathic pain disorders.

CJ challenged the validity of the Lyrica patent a...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.